Quote:
Originally Posted by jfman
I'm not sure the point you are arguing to be honest.
Clearly the manufacturers are holding exclusive rights over their own vaccines. This isn't surprising - it's industry standard.
Nobody can just open a plant in India, China or elsewhere and start making the vaccines at cost without infringing on the rights of Pfizer, Astrazenica, Moderna or anyone else who has a successful vaccine candidate.
|
You stated "If we are truly interested in the “entire planet”
we should remove the IP rights on all vaccines and get production ramped up.". What difference would that make unless there has been a block on somebody producing it?
It takes time to expand an existing plant or open a new one. Eg Some French investment of June 2020 has yet to come online.
The UK benefited from government investment in vaccine production before last year. We got ahead of the game.
Link
Quote:
In 2018, UKRI announced £66 million for the UK’s first dedicated Vaccine Manufacturing Innovation Centre (VMIC). The goal was to promote, develop and accelerate the growth of the UK vaccine industry.
Also in 2018, the Vaccine Manufacturing and Research Centre was established by the Engineering and Physical Sciences Research Council (EPSRC).
This was to find new ways to support vaccine manufacturing and delivery in low and middle income countries.
Alongside these landmark projects, UKRI funded many others to ensure the UK would have the capability to manufacture and distribute a vaccine when the time came.
|